Publications & Thought Leadership

Alkemi Has Been Featured In 80+ Publications

Alkemi represents the voice of the global conversation on health economics and market access. Our work is published in leading journals and presented at major conferences worldwide. Each publication reflects the urgency, rigor, and cross-functional alignment that set Alkemi apart.

Where We’re Published

Blood journal logo with circular red emblem and the word 'blood' in red serif font.Neurology journal logo.Text reading 'Value in Health' in large, light brown font on white background.Text logo reading 'THE AMERICAN JOURNAL OF MANAGED CARE' with 'MANAGED CARE' in large blue uppercase letters.AMCP Academy of Managed Care Pharmacy logo with blue initials and black text separated by a vertical line.The Journal of Urology text logo in red font.Green square with the word 'Cancer' in white lowercase letters.Logo of ISPOR featuring a green globe with the text ISPOR in bold and the full name International Society for Pharmacoeconomics and Outcomes Research encircling it.ISPOR logo with the tagline 'Improving healthcare decisions'.

Publications & Presentations

Rare Disease
Literature Review
Manuscript
2026

PROM-ising Progress? Trends in Patient- and Clinician-Reported Outcome Measures in US Food and Drug Administration Orphan Drug Labels

Value in Health

Cribbs KA, Blackmore LTA, McGovern MR, Lahue BJ


Other
Literature Review
Conference Astract/oster
2025

Delivering Pharma Value: Where Is the Optimal Home for Health Economics and Outcomes Research (HEOR)?

ISPOR 2025

Betsy JH., Shuvayu S.


Autoimmune
Claims
Conference Abstract/Poster
2025

Real-world Safety Assessment of Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with Subcutaneous IgPro20

PNS 2024, Neurology

Divino V, Mallick R, Lahue B, Coyle K, Wang Y, DeKoven M, Hubsch A


Neurology
Literature Review
Manuscript
2025

An Evaluation of the Real-World Effectiveness of Immunoglobulin Therapy in Chronic Inflammatory Demyelinating Polyneuropathy

Neurology and Therapy

Hubsch, A., Divino, V., Mallick, R., Coyle K., Langford E., Wang Y., Ida F., Lahue BJ., Zhang X.


Neurology
Literature Review
Conference Abstract/Poster
2025

G17 Expected costs and costs per responder of Hizentra in comparison with other maintenance therapies for chronic inflammatory demyelinating polyneuropathy in the United States

AMCP Annual Meeting 2025, JMCP

Tran D, Mallick R, Patel B, Henry C, Hubsch A, Li Y, Lahue BJ


Oncology
Literature Review
Conference Abstract/Poster
2025

Underreporting of prognostic factors in real-world studies for bispecifics in relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL)

ASH

Xavier M, Baginska E, Jun M, Branchcomb T, Mutebi A, Tybor D, Wang A, Cribbs K, Lahue B


Rare Disease
Literature Review
Manuscript
2025

Capturing Real‐World Rare Disease Patient Journeys: Are Current Methodologies Sufficient for InformedHealthcare Decisions?

Journal of Evaluation in Clinical Practice

Cribbs KA, Blackmore LTA, Banks AR, Kim DS, Lahue BJ


Oncology
Economic
Conference Abstract/Poster
2025

PCR231 Beyond the Numbers: Measuring the Real-Life Impact of Medical Treatments via Patient-Level Modeling

ISPOR 2025, Value in Health 28(S1)

Kristen A. Cribbs; Ethan Donnelly; Linda Upchurch; Samantha Watson; Betsy J. Lahue


Rare Disease
Policy Review
Conference Abstract/Poster
2025

PT14 Do Breakthrough Therapies Demonstrate Breakthrough Value to Payers? An Evaluation of US Hemophilia B Gene Therapy Access Policies

ISPOR 2025, Value in Health 28(S1)

Lake D. Murphy; Betsy J. Lahue


Autoimmune
Literature Review
Conference Abstract/Poster
2025

Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin and Efgartigimod Alfa in Patients with Chronic Inflammatory Demyelinating Polyneuropathy in the United States

AAN Annual Meeting 2025, eurology

Hubsch A, Mallick R, Carlton R, van Stiphout J, Lahue BJ


Rare Disease
Literature Review
Manuscript
2025

Capturing Real-World Rare Disease Patient Journeys: Are Current Methodologies Sufficient for Informed Healthcare Decisions?

Journal of Evaluation in Clinical Practice

Kristen A. Cribbs; Lucas T. A. Blackmore; Asia R. Banks; Da Sol Kim; Betsy J. Lahue


Rare Disease
Literature Review
Conference Abstract/Poster
2025

PCR25 PROM-ising Progress? Patient-Reported Outcome Measures in Orphan Labels

ISPOR 2025, Value in Health 28(S1)

Kristen A. Cribbs; Lucas T. Blackmore; Betsy J. Lahue


Oncology
Literature Review
Manuscript
2025

Clinical and safety outcomes in unresectable, very early and early-stage hepatocellular carcinoma following Irreversible Electroporation (IRE) and Transarterial Chemoembolization (TACE): A systematic literature review and meta-analysis

PLOS ONE

Kristen A. Cribbs; Wesley T. Baisley; Betsy J. Lahue; Praveen Peddu


Rare Disease
Literature Review
Conference Abstract/Poster
2025

Clinician-Reported Outcomes - A Rare Opportunity for Orphan Labels?

ISPOR 2025, Value in Health 28(S1)

Kristen A. Cribbs; Lucas T. Blackmore; Betsy J. Lahue


Rare Disease
Literature Review
Manuscript
2025

PROM-ising Progress? Trends in Patient- and Clinician-Reported Outcome Measures in FDA Orphan Drug Labels

Value in Health

Kristen A. Cribbs; Lucas T. A. Blackmore; Michael R. McGovern; Betsy J. Lahue


None
Literature Review
Manuscript
2024

Assessing the Clinical, Economic, and Health Resource Utilization Impacts of Prefilled Syringes Versus Conventional Medication Administration Methods: Results From a Systematic Literature Review

The Annals of Pharmacotherapy

Benhamou D, Weiss M, Borms M, Lucaci J, Haymen G, Frolet C, Baisley W, Shoushi G, Cribbs KA, Wenk M


None
Literature Review
Conference Abstract/Poster
2024

Does Availability of Rare Disease Treatment Improve Time to Diagnosis?

ISPOR 2024

Baisley W


Rare Disease
Literature Review
Conference Abstract/Poster
2024

Capturing real-world rare disease patient journeys: Are current methodologies sufficient?

ISPOR EU 2024

Cribbs KA, Blackmore LTA, Banks AR, Kim DS, Lahue BJ


None
Policy Review
Panel/Workshop/Discussion
2024

How to Navigate the Digital Health Landscape: Global Value Frameworks and Payment Pathways

ISPOR 2024

Lahue BJ, Chandran A, Hernandez J


Rare Disease
Economic
Conference Abstract/Poster
2024

Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin and Efgartigimod Alfa in Patients with CIDP in the United States (P10-11.028)

AAN 2025, Neurology 104(7_Supplement_1)

Rajiv Mallick; Alphonse Hubsch; Rashad Carlton; Joris van Stiphout; Betsy Lahue


Autoimmune
Claims
Conference Abstract/Poster
2024

Real-world Safety Assessment of Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with Subcutaneous IgPro20

PNS 2024

Divino V, Mallick R, Lahue B, Coyle K, Wang Y, DeKoven M, Hubsch A


None
Policy Review
Conference Abstract/Poster
2024

Real World Evidence and Rare Disease Considerations Across Regulatory and Health Technology Assessment Frameworks in the US, UK, and Canada

ISPOR 2024

Blackmore LTA, Cribbs KA, Lahue BJ


None
Literature Review
Conference Abstract/Poster
2024

Can Artificial Intelligence Tools Enhance Data Abstraction During Systematic Literature Reviews?

ISPOR 2024

Cribbs KA, Baisley W, Blackmore LTA, Lahue BJ


None
Economic
Conference Abstract/Poster
2024

Economic Evaluations of Digital Health Interventions: Is Existing Guidance Being Used?

ISPOR 2024

Baisley W, Lahue BJ


None
Literature Review
Conference Abstract/Poster
2024

An Investigation of Patient Journey Assessment in Rare Disease

ISPOR 2024

Cribbs KA, Kim DS, Lahue BJ


Autoimmune
Economic
Conference Abstract/Poster
2024

Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin, and Efgartigimod Alfa in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in the United States

ISPOR 2024, Value in Health

Mallick R, Carlton R, van Stiphout J, Hubsch A, Lahue BJ


Autoimmune
Literature Review
Conference Abstract/Poster
2024

Budget impact of subcutaneous immunoglobulin, intravenous immunoglobulin and Efgartigimod Alfa in patients with chronic inflammatory demyelinating polyneuropathy in the United States

American Health -System Pharmacy (ASHP mid-year) 2024, Am J Health-Syst Pharm

Hubsch A, Mallick R, Carlton R, van Stiphout J, Lahue BJ


Oncology
Economic
Conference Abstract/Poster
2023

Practice efficiency of treatment with epcoritamab versus glofitamab in relapsed/refractory diffuse large B-cell lymphoma

ASCO 2023

Meyer K, Huang D, O'Day K, Lahue BJ


Oncology
Survey
Conference Abstract/Poster
2023

Burden of Systemic Mastocytosis in Europe and the UK: Interim Results from PRISM Patient Survey

ECRD 2024, Value in Health

Hobart J, Radia DH, Triggiani M, Butt NM, Drummond M, Baisley W, Lahue BJ, Green T, Powell D, Gressier-Sayag C, Mesa R


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Assessing the Potential Benefits of Oral Therapies in Hereditary Angioedema

Academy of Managed Care Pharmacy (AMCP) Conference

Soteres DF, Cribbs KA, Guo W, Czado S


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Characterizing Attack-Related Health Utility in Hereditary Angioedema

ISPOR 2023

Craig TJ, Cribbs KA, Czado S


Autoimmune
Literature Review
Conference Abstract/Poster
2023

A Systematic Review of Healthcare Resource Utilization and Direct Medical Costs in Hereditary Angioedema

ISPOR 2023

Craig TJ, Cribbs KA, Czado S


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Assessing the Burden of Injection with Parenteral Hereditary Angioedema Therapies

ISPOR 2023

Soteres DF, Cribbs KA, Czado S


Autoimmune
Literature Review
Conference Abstract/Poster
2023

PCR81 Diagnosis and Treatment Patterns in European Patients with Systemic Mastocytosis

ISPOR EU 2023, Value in Health

Triggiani M, Mesa R, Hobart J, Green T, Powell D, Gressier-Sayag C, Baisley W, Lahue BJ, Rueff F, Schinhofen W, Hegmann N, Livideanu CB, Beaux A, Marcis P, Alvarez-Twose I, Ribada E, Radia D, Finnerty CC


Autoimmune
Literature Review
Manuscript
2023

Assessing the Utility of Existing Hereditary Angioedema Disease Models for Health Economic Evaluation of Future Therapies

ISPOR 2023

Schwander B, Lahue BJ, Cribbs KA, Czado S


Autoimmune
Survey
Conference Abstract/Poster
2023

The Burden of Systemic Mastocytosis in the EU: Evidence From the PRISM Patient Survey

ISPOR EU 2023

Mesa R, Triggiani M, Hobart J, Green T, Powell D, Gressier-Sayag C, Baisley W, Lahue BJ, Rueff F, Schinhofen W, Hegmann N, Livideanu CB, Beaux A, Marcis P, Alvarez-Twose I, Ribada E, Radia D, Finnerty CC


Autoimmune
Claims
Conference Abstract/Poster
2023

Treatment Patterns Among Individuals with Hereditary Angioedema in the United States

Annals of Allergy, Asthma & Immunology

Tachdjian R, Chang R, DerSarkissian M, Cribbs K, Lahue B, Czado S, Desai V


Oncology
Literature Review
Manuscript
2023

Real-World Comparative Safety and Effectiveness of Irreversible Electroporation and High-Intensity Focused Ultrasound for Prostate Cancer Ablation

Urology

Cribbs KA, Manning EF, Zhou J, Lahue BJ, Polascik TJ


None
Economic
Manuscipt
2023

Creating an evidence-based economic model for prefilled parenteral medication delivery in the hospital setting

European Journal of Hospital Pharmacy

Eijsink JFH, Weiss M, Taneja A, Edwards T, Girgis H, Lahue BJ, Cribbs KA, Postma M


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Current State of Health Economic Models in Hereditary Angioedema

ISPOR EU 2023

Tachdjian R, Lahue BJ, Cribbs KA, Fang DK, Czado S, Goga L, Desai V, Rautenberg T, Schwander B


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Assessing the Burden of Injection with Parenteral Hereditary Angioedema Therapies

ISPOR 2023

Soteres DF, Cribbs KA, Czado S


Autoimmune
Literature Review
Manuscript
2023

A Systematic Review of Socioeconomic Burden in Hereditary Angioedema

ISPOR 2023

Soteres DF, Cribbs KA, Czado S


Oncology
Economic
Manuscript
2023

Practice efficiency of treatment with epcoritamab versus glofitamab in relapsed/refractory diffuse large B-cell lymphoma

ASCO 2023

Meyer K, Huang D, O'Day K, Lahue BJ


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Diagnosis Patterns in Patients with Systemic Mastocytosis in Europe and United Kingdom

ISPOR EU 2023

Triggiani M, Mesa R, Hobart J, Green T, Powell D, Gressier-Sayag C, Baisley W, Lahue BJ, Rueff F, Schinhofen W, Hegmann N, Livideanu CB, Beaux A, Marcis P, Alvarez-Twose I, Ribada E, Radia D, Finnerty CC


Oncology
Survey
Manuscript
2023

Assessment of Physician Treatment Preferences for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

National Comprehensive Cancer Network, Journal of the National Comprehensive Cancer Network

Gao W, Gaburo K, Lahue B, Davies K, Ukropec J, Jun M


Autoimmune
Literature Review
Manuscript
2023

Characterizing Attack-Related Health Utility in Hereditary Angioedema

ISPOR 2023

Craig TJ, Cribbs KA, Czado S


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Assessing the Potential Benefits of Oral Therapies in Hereditary Angioedema

Academy of Managed Care Pharmacy (AMCP) Conference

Soteres DF, Cribbs KA, Guo W, Czado S


None
Literature Review
Conference Abstract/Poster
2023

Non-Systematic Literature Reviews: Can AI enhance current methods?

ISPOR EU 2023

Baisley W, Perriello L, Shoushi G, Lahue BJ


Autoimmune
Literature Review
Manuscript
2023

A Systematic Review of Healthcare Resource Utilization and Direct Medical Costs in Hereditary Angioedema

ISPOR 2023

Craig TJ, Cribbs KA, Czado S


None
Economic
Manuscript
2023

Creating an evidence-based economic model for prefilled parenteral medication delivery in the hospital setting

European Journal of Hospital Pharmacy

Eijsink JFH, Weiss M, Taneja A, Edwards E, Girgis H, Lahue BJ, Cribbs KA, Postma M


Autoimmune
Claims
Manuscript
2022

Reduced risk of infections with the intravenous immunoglobulin, IgPro10, in patients at risk of secondary immunodeficiency-related infections

Immunotherapy

Lahue BJ, Mallick R, Zhang X, Heidt J, Song Y, Koenig AS, Espinoza G


None
Economic
Manuscript
2022

Making the case for pre-filled syringes: development and utilisation of an economic model

European Journal of Hospital Pharmacy

Postma MJ, Weiss M, Edwards T, Girgis H, Cribbs K, Acker E, Lahue BJ


Oncology
Survey
Manuscript
2022

Patient-reported outcomes among patients with systemic mastocytosis in routine clinical practice: results of the TouchStone SM Patient Survey

Cancer

Mesa RA, Sullivan EM, Dubinski D, Carroll B, Slee VM, Jennings SV, Finnerty CC, Bohannon LS, Mathias SD, Lahue BJ, Castells MC


Oncology
Survey
Manuscript
2022

Perceptions of patient disease burden and management approaches in systemic mastocytosis: Results of the TouchStone Healthcare Provider Survey

Cancer

Mesa RA, Sullivan EM, Dubinski D, Carroll B, Slee VM, Jennings SV, Finnerty CC, Bohannon LS, Mathias SD, Lahue BJ, Castells MC


Autoimmune
Claims
Manuscript
2021

Infections in Secondary Immunodeficiency Patients Treated with IgPro10: A Real‑World Analysis of Patients, Including Those with Hematological Malignancies

Blood

Lahue B, Mallick R, Zhang X, Koenig AS, Espinoza G


Autoimmune
Claims
Conference Abstract/Poster
2021

Infections in Secondary Immunodeficiency Patients Treated with IgPro10: Real World Analysis of Patients, Including Those with Hematological Malignancies

American Society of Hematology Annual Meeting (ASH) 2021

Lahue B, Mallick R, Zhang X, Koenig AS, Espinoza G


Infectious
Other
Manuscript
2020

Investigating the Impact of the Nursing Practice Environment (NPE) on Central Line- Associated Bloodstream Infections (CLABSI) among Older Adults in the Intensive Care Unit (ICU)

CUNY SPH: Dissertations and Theses

Cribbs K


Oncology
Claims
Manuscript
2020

Real-World Clinical Outcomes of Patients with Myelofibrosis Treated with Ruxolitinib: Evidence from a Multinational Medical Record Review

American Society of Hematology Annual Meeting (ASH), Blood

Passamonti F, Heidel FH, Parikh RC, Tang D, Lahue BJ, Nadal JA, Davis KL, Ajmera M, Kee A, Abraham P


Autoimmune
Survey
Manuscript
2020

Subcutaneous immunoglobulin in primary immunodeficiency – impact of training and infusion characteristics on patient-reported outcomes

BMC Immunology

Mallick R, Henderson T, Lahue BJ, Kafal A, Bassett P, Scalchunes C


Oncology
Claims
Manuscript
2020

Real-World Clinical Outcomes of Patients with Myelofibrosis Treated with Ruxolitinib: Evidence from a Multinational Medical Record Review

Blood

Passamonti F, Heidel FH, Parikh RC, Tang D, Lahue BJ, Nadal JA, Davis KL, Ajmera M, Kee A, Abraham P


Oncology
Economic
Conference Abstract/Poster
2019

PCN102 Impact of Global Indication Sequencing on Drug Pricing and Access in Oncology: Potential Implications of Using a Price-Based Commercial Sequencing Strategy

Value in Health, ISPOR 2019

M. Klietmann, Crowther A.


None
Other
Manuscript
2019

Enhancing graduate practicum project development and selection at schools of public health: A case study

Pedagogy in Health Promotion

Cribbs K, Lynch S, LaMonica M, Amadi C, Joshi A


Mental Health
Other
Manuscript
2018

Home care workers’ experiences of client death and disenfranchised grief

Qualitative Health Research

Tsui EK, Franzosa E, Cribbs KA, Baron S


None
Qualitative
Manuscript
2017

The everyday food practices of community-dwelling Lesbian, Gay, Bisexual, and Transgender (LGBT) older adults

Journal of Aging Studies

Cohen N, Cribbs KA


Endocrine
Policy Review
Article/Report
2015

Can mHealth Revolutionize Evidence-Based Practice in Diabetes Care?

American Journal of Managed Care

Lahue BJ, Hughes K, Hills BJ, Li SS, Hiatt JC


Oncology
Policy Review
Manuscript
2015

Health technology assessment on cervical cancer screening, 2000-2014

Int J Technol Assess Health Care

Lahue BJ, Baginska E, Li SS, Parisia M


Endocrine
Claims
Manuscript
2015

Adherence to Insulin Pen Therapy is Associated with Reduction in Healthcare Costs Among Patients with Type 2 Diabetes Mellitus

American Health Drug Benefits

Chandran A, Bonafede MK, Nigam S, Saltiel-Berzin R, Hirsch LJ, Lahue BJ


Infectious
Economic
Manuscript
2014

Controlling Vaccine Wastage with Smaller Vials: A Cost-Minimization Model for Bangladesh, Mozambique, India (Uttar Pradesh), and Uganda

7th Annual Vaccine and ISV Congress

Yang W, Parisi M, Lahue B, Uddin J, Bishai D


Infectious
Economic
Manuscipt
2014

The budget impact of controlling wastage with smaller vials: A data driven model of session sizes in Bangladesh, India (Uttar Pradesh), Mozambique and Uganda

Vaccine

Yang W, Parisi M, Lahue BJ, Uddin MJ, Bishai D


None
Literature Review
Manuscript
2014

A Systematic Review of the Effectiveness of Health Information Technology Interventions in Improving Medication Adherence

19th Annual ISPOR

Nigam S, Mitra D, Lahue BJ


Endocrine
Claims
Conference Abstract/Poster
2014

Pen Needle Length And Persistence Among Insulin Pen Users With Type 2 Diabetes Mellitus

ISPOR 2014

Manocchio J, Chandran A, Bonafede MM, Saltiel-Berzin R, Hirsch LJ, Lahue BJ


Mental Health
Qualitative
Manuscript
2013

Advocacy at the end of life: Meeting the needs of vulnerable patients

Social Work in Health Care

Nedjat-Haiem FR, Carrion IV, Cribbs K, Lorenz K


None
Claims
Manuscript
2013

Characterization of Injectable Medication Errors in the Hospital Setting: A Retrospective Analysis

18th Annual ISPOR

Baginska EA, Kelley L, Lahue BJ


Infectious
Economic
Manuscript
2013

Examining the Impact of Country-level Factors of Vaccine Wastage: A Data Driven Model of Session Sizes in Bangladesh, Mozambique, India (Uttar Pradesh), and Uganda

16th Annual ISPOR European Congress

Yang W, Parisi M, Lahue B, Uddin J, Bishai D


Endocrine
Claims
Manuscipt
2013

Burden of Health Resource Utilization Among Insulin Pen Users with Type 2 Diabetes Mellitus

18th Annual ISPOR

Chandran A, Bonafede MK, Nigam S, Saltiel-Berzin R, Hirsch LJ, Lahue BJ


Endocrine
Claims
Manuscipt
2013

Adherence to Insulin Therapy may Substantially Reduce Costs Associated with Health Resource Utilization among Insulin Pen Users with Type II Diabetes Mellitus

18th Annual ISPOR

Chandran A, Bonafede MK, Nigam S, Saltiel-Berzin R, Hirsch LJ, Lahue BJ


Oncology
Economic
Manuscript
2012

National burden of preventable adverse drug events associated with inpatient injectable medications: healthcare and medical professional liability costs

American Health Drug Benefits

Lahue BJ, Pyenson B, Iwasaki K, Blumen HE, Forray S, Rothschild JM


Oncology
Literature Review
Manuscript
2012

Data Linkage For Cervical Cancer Outcomes: Is There an Evidence Base for Public Health Decision-Making?

17th Annual ISPOR

Lahue BJ, Lin AY, Crilly HJ


Oncology
Policy Review
Manuscript
2012

A Review of Health Technology Assessments (HTA) for Cervical Cancer Screening Technologies

17th Annual ISPOR

Lahue BH, Baginska E


Nephrology
Economic
Conference Abstract/Poster
2010

Decreased Epoetin Utilization Associated with Conversion to Ferumoxytol IV Iron Protocol

American Society of Nephrology (ASN) Renal Week Meeting

Sharma A, Lahue BJ


Nephrology
Economic
Conference Abstract/Poster
2010

Efficiency Outcomes Associated with Increased Ferumoxtyol Use in an Infusion Clinic

American Society of Hematology Annual Meeting (ASH)

Meyers M, Erdal E, Khan C, McKee A, Lahue BJ


Infectious
Economic
Conference Abstract/Poster
2009

Consequences of Hepatitis C Virus (HCV): Costs of a Baby Boomer Epidemic of Liver Disease

Milliman Actuarial White Paper

Fitch K, Iwasaki K, Pyenson B


None
Economic
Manuscript
2008

Inclusion of indirect cost in economic outcome analyses of medical devices: How important is it?

6th Annual International Society of Pharmacoeconomics and Outcomes Research

Subramanian S, [Lahue] Justason BJ


Infectious
Claims
Conference Abstract/Poster
2007

Does First-line Therapy Impact Clostridium difficile-associated Disease (CDAD) Recurrence Hospitalizations?

Infectious Diseases Society of America (IDSA) Annual Meeting

Lahue BJ


Endocrine
Economic
Conference Abstract/Poster
2007

Economic Impact of Hydro ThermAblater® (HTA) Endometrial Ablation versus Hysterectomy for Dysfunctional Uterine Bleeding (DUB)

American Association of Gynecologic Laparoscopy

[Lahue] Justason BJ


Infectious
Economic
Manuscript
2007

The Emerging Infectious Challenge of Clostridium difficile-Associated Disease in Massachusetts Hospitals: Clinical and Economic Consequences

Journal of Infection Control and Hospital Epidemiology

O'Brien JA, Lahue BJ, Caro JJ, Davidson DM


Neurology
Economic
Manuscript
2007

Treatment of Unruptured Intracranial Aneurysms: A Nationwide Assessment of Effectiveness

American Journal of Neuroradiology

Higashida RT, Lahue BJ, Torbey MT, Hopkins LN, Leip E, Hanley DF


Cardiovascular
Economic
Manuscript
2006

TAXUS-IV Investigators. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial

J Am Coll Cardiol

Bakhai A, Stone GW, Mahoney E, Lavelle TA, Shi C, Berezin RH, Lahue BJ, Clark MA, Lacey MJ, Russell ME, Ellis SG, Hermiller JB, Cox DA, Cohen DJ


Infectious
Claims
Conference Abstract/Poster
2006

Increased Management Needs, Functional Dependency and Staff Resources for Nursing Home Residents with Clostridium difficile-Associated Diarrhea (CDAD)

29th Annual Symposium American Medical Directors Association

Lahue BJ


Infectious
Economic
Conference Abstract/Poster
2006

Clostridium Difficile-Associated Diarrhea (CDAD) In Acute Hospitals - A Prevalent Cost Issue

ISPOR 2006

OBrien JA, PitoniakMorse C, Lahue BJ, Davidson D, Wilson D, Caro JJ


Cardiovascular
Claims
Manuscript
2005

Medicare costs and health care resource utilization associated with atrial fibrillation in the elderly

Journal of Medical Economics

Pelletier EM, Hernandez J, Clark MA, Lahue BJ, Reyes CM, Morady F


Infectious
Other
Conference Abstract/Poster
2005

Using advanced simulation modeling to examine the impact of increased resources on patient throughput in outpatient care

Value in Health

Lahue BJ, Lacey MJ, Dronzek R


Infectious
Economic
Conference Abstract/Poster
2004

Patient Throughput and Staff Efficiency in an Outpatient Health Care Setting

6th Annual Simulation Solutions Conference

[Lahue] Justason BJ


None
Survey
Article Report
2001

The Impact of Educational Home Visits on Children at Risk for Lead Poisoning

Centers For Disease Control Annual Grantees Meeting

[Lahue] Justason BJ


Mental Health
Other
Manuscript
2001

Severity, Manifestations, and Consequences of Violence among Pregnant Adolescents

Journal of Adolescent Health

Covington DL, [Lahue] Justason BJ, Wright LN


Other (Neonatal & Opthamology)
Other
Conference Abstract/Poster
2000

Use of Continuous Quality Improvement Principles to Increase Preventive Screenings in High-Risk Infants

128th American Public Health Association Annual Meeting and Exposition

[Lahue] Justason BJ, Sachariat ML, McArtor RD


Autoimmune
Claims
Conference Abstract/Poster
2025

Real-world Safety Assessment of Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with Subcutaneous IgPro20

PNS 2024, Neurology

Divino V, Mallick R, Lahue B, Coyle K, Wang Y, DeKoven M, Hubsch A


Autoimmune
Literature Review
Conference Abstract/Poster
2025

Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin and Efgartigimod Alfa in Patients with Chronic Inflammatory Demyelinating Polyneuropathy in the United States

AAN Annual Meeting 2025, eurology

Hubsch A, Mallick R, Carlton R, van Stiphout J, Lahue BJ


Autoimmune
Claims
Conference Abstract/Poster
2024

Real-world Safety Assessment of Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with Subcutaneous IgPro20

PNS 2024

Divino V, Mallick R, Lahue B, Coyle K, Wang Y, DeKoven M, Hubsch A


Autoimmune
Economic
Conference Abstract/Poster
2024

Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin, and Efgartigimod Alfa in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in the United States

ISPOR 2024, Value in Health

Mallick R, Carlton R, van Stiphout J, Hubsch A, Lahue BJ


Autoimmune
Literature Review
Conference Abstract/Poster
2024

Budget impact of subcutaneous immunoglobulin, intravenous immunoglobulin and Efgartigimod Alfa in patients with chronic inflammatory demyelinating polyneuropathy in the United States

American Health -System Pharmacy (ASHP mid-year) 2024, Am J Health-Syst Pharm

Hubsch A, Mallick R, Carlton R, van Stiphout J, Lahue BJ


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Assessing the Potential Benefits of Oral Therapies in Hereditary Angioedema

Academy of Managed Care Pharmacy (AMCP) Conference

Soteres DF, Cribbs KA, Guo W, Czado S


Autoimmune
Literature Review
Conference Abstract/Poster
2023

A Systematic Review of Healthcare Resource Utilization and Direct Medical Costs in Hereditary Angioedema

ISPOR 2023

Craig TJ, Cribbs KA, Czado S


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Assessing the Burden of Injection with Parenteral Hereditary Angioedema Therapies

ISPOR 2023

Soteres DF, Cribbs KA, Czado S


Autoimmune
Literature Review
Conference Abstract/Poster
2023

PCR81 Diagnosis and Treatment Patterns in European Patients with Systemic Mastocytosis

ISPOR EU 2023, Value in Health

Triggiani M, Mesa R, Hobart J, Green T, Powell D, Gressier-Sayag C, Baisley W, Lahue BJ, Rueff F, Schinhofen W, Hegmann N, Livideanu CB, Beaux A, Marcis P, Alvarez-Twose I, Ribada E, Radia D, Finnerty CC


Autoimmune
Literature Review
Manuscript
2023

Assessing the Utility of Existing Hereditary Angioedema Disease Models for Health Economic Evaluation of Future Therapies

ISPOR 2023

Schwander B, Lahue BJ, Cribbs KA, Czado S


Autoimmune
Survey
Conference Abstract/Poster
2023

The Burden of Systemic Mastocytosis in the EU: Evidence From the PRISM Patient Survey

ISPOR EU 2023

Mesa R, Triggiani M, Hobart J, Green T, Powell D, Gressier-Sayag C, Baisley W, Lahue BJ, Rueff F, Schinhofen W, Hegmann N, Livideanu CB, Beaux A, Marcis P, Alvarez-Twose I, Ribada E, Radia D, Finnerty CC


Autoimmune
Claims
Conference Abstract/Poster
2023

Treatment Patterns Among Individuals with Hereditary Angioedema in the United States

Annals of Allergy, Asthma & Immunology

Tachdjian R, Chang R, DerSarkissian M, Cribbs K, Lahue B, Czado S, Desai V


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Current State of Health Economic Models in Hereditary Angioedema

ISPOR EU 2023

Tachdjian R, Lahue BJ, Cribbs KA, Fang DK, Czado S, Goga L, Desai V, Rautenberg T, Schwander B


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Assessing the Burden of Injection with Parenteral Hereditary Angioedema Therapies

ISPOR 2023

Soteres DF, Cribbs KA, Czado S


Autoimmune
Literature Review
Manuscript
2023

A Systematic Review of Socioeconomic Burden in Hereditary Angioedema

ISPOR 2023

Soteres DF, Cribbs KA, Czado S


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Diagnosis Patterns in Patients with Systemic Mastocytosis in Europe and United Kingdom

ISPOR EU 2023

Triggiani M, Mesa R, Hobart J, Green T, Powell D, Gressier-Sayag C, Baisley W, Lahue BJ, Rueff F, Schinhofen W, Hegmann N, Livideanu CB, Beaux A, Marcis P, Alvarez-Twose I, Ribada E, Radia D, Finnerty CC


Autoimmune
Literature Review
Manuscript
2023

Characterizing Attack-Related Health Utility in Hereditary Angioedema

ISPOR 2023

Craig TJ, Cribbs KA, Czado S


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Assessing the Potential Benefits of Oral Therapies in Hereditary Angioedema

Academy of Managed Care Pharmacy (AMCP) Conference

Soteres DF, Cribbs KA, Guo W, Czado S


Autoimmune
Literature Review
Manuscript
2023

A Systematic Review of Healthcare Resource Utilization and Direct Medical Costs in Hereditary Angioedema

ISPOR 2023

Craig TJ, Cribbs KA, Czado S


Autoimmune
Claims
Manuscript
2022

Reduced risk of infections with the intravenous immunoglobulin, IgPro10, in patients at risk of secondary immunodeficiency-related infections

Immunotherapy

Lahue BJ, Mallick R, Zhang X, Heidt J, Song Y, Koenig AS, Espinoza G


Autoimmune
Claims
Manuscript
2021

Infections in Secondary Immunodeficiency Patients Treated with IgPro10: A Real‑World Analysis of Patients, Including Those with Hematological Malignancies

Blood

Lahue B, Mallick R, Zhang X, Koenig AS, Espinoza G


Autoimmune
Claims
Conference Abstract/Poster
2021

Infections in Secondary Immunodeficiency Patients Treated with IgPro10: Real World Analysis of Patients, Including Those with Hematological Malignancies

American Society of Hematology Annual Meeting (ASH) 2021

Lahue B, Mallick R, Zhang X, Koenig AS, Espinoza G


Autoimmune
Survey
Manuscript
2020

Subcutaneous immunoglobulin in primary immunodeficiency – impact of training and infusion characteristics on patient-reported outcomes

BMC Immunology

Mallick R, Henderson T, Lahue BJ, Kafal A, Bassett P, Scalchunes C


Cardiovascular
Economic
Manuscript
2006

TAXUS-IV Investigators. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial

J Am Coll Cardiol

Bakhai A, Stone GW, Mahoney E, Lavelle TA, Shi C, Berezin RH, Lahue BJ, Clark MA, Lacey MJ, Russell ME, Ellis SG, Hermiller JB, Cox DA, Cohen DJ


Cardiovascular
Claims
Manuscript
2005

Medicare costs and health care resource utilization associated with atrial fibrillation in the elderly

Journal of Medical Economics

Pelletier EM, Hernandez J, Clark MA, Lahue BJ, Reyes CM, Morady F


Endocrine
Policy Review
Article/Report
2015

Can mHealth Revolutionize Evidence-Based Practice in Diabetes Care?

American Journal of Managed Care

Lahue BJ, Hughes K, Hills BJ, Li SS, Hiatt JC


Endocrine
Claims
Manuscript
2015

Adherence to Insulin Pen Therapy is Associated with Reduction in Healthcare Costs Among Patients with Type 2 Diabetes Mellitus

American Health Drug Benefits

Chandran A, Bonafede MK, Nigam S, Saltiel-Berzin R, Hirsch LJ, Lahue BJ


Endocrine
Claims
Conference Abstract/Poster
2014

Pen Needle Length And Persistence Among Insulin Pen Users With Type 2 Diabetes Mellitus

ISPOR 2014

Manocchio J, Chandran A, Bonafede MM, Saltiel-Berzin R, Hirsch LJ, Lahue BJ


Endocrine
Claims
Manuscipt
2013

Burden of Health Resource Utilization Among Insulin Pen Users with Type 2 Diabetes Mellitus

18th Annual ISPOR

Chandran A, Bonafede MK, Nigam S, Saltiel-Berzin R, Hirsch LJ, Lahue BJ


Endocrine
Claims
Manuscipt
2013

Adherence to Insulin Therapy may Substantially Reduce Costs Associated with Health Resource Utilization among Insulin Pen Users with Type II Diabetes Mellitus

18th Annual ISPOR

Chandran A, Bonafede MK, Nigam S, Saltiel-Berzin R, Hirsch LJ, Lahue BJ


Endocrine
Economic
Conference Abstract/Poster
2007

Economic Impact of Hydro ThermAblater® (HTA) Endometrial Ablation versus Hysterectomy for Dysfunctional Uterine Bleeding (DUB)

American Association of Gynecologic Laparoscopy

[Lahue] Justason BJ


Infectious
Other
Manuscript
2020

Investigating the Impact of the Nursing Practice Environment (NPE) on Central Line- Associated Bloodstream Infections (CLABSI) among Older Adults in the Intensive Care Unit (ICU)

CUNY SPH: Dissertations and Theses

Cribbs K


Infectious
Economic
Manuscript
2014

Controlling Vaccine Wastage with Smaller Vials: A Cost-Minimization Model for Bangladesh, Mozambique, India (Uttar Pradesh), and Uganda

7th Annual Vaccine and ISV Congress

Yang W, Parisi M, Lahue B, Uddin J, Bishai D


Infectious
Economic
Manuscipt
2014

The budget impact of controlling wastage with smaller vials: A data driven model of session sizes in Bangladesh, India (Uttar Pradesh), Mozambique and Uganda

Vaccine

Yang W, Parisi M, Lahue BJ, Uddin MJ, Bishai D


Infectious
Economic
Manuscript
2013

Examining the Impact of Country-level Factors of Vaccine Wastage: A Data Driven Model of Session Sizes in Bangladesh, Mozambique, India (Uttar Pradesh), and Uganda

16th Annual ISPOR European Congress

Yang W, Parisi M, Lahue B, Uddin J, Bishai D


Infectious
Economic
Conference Abstract/Poster
2009

Consequences of Hepatitis C Virus (HCV): Costs of a Baby Boomer Epidemic of Liver Disease

Milliman Actuarial White Paper

Fitch K, Iwasaki K, Pyenson B


Infectious
Claims
Conference Abstract/Poster
2007

Does First-line Therapy Impact Clostridium difficile-associated Disease (CDAD) Recurrence Hospitalizations?

Infectious Diseases Society of America (IDSA) Annual Meeting

Lahue BJ


Infectious
Economic
Manuscript
2007

The Emerging Infectious Challenge of Clostridium difficile-Associated Disease in Massachusetts Hospitals: Clinical and Economic Consequences

Journal of Infection Control and Hospital Epidemiology

O'Brien JA, Lahue BJ, Caro JJ, Davidson DM


Infectious
Claims
Conference Abstract/Poster
2006

Increased Management Needs, Functional Dependency and Staff Resources for Nursing Home Residents with Clostridium difficile-Associated Diarrhea (CDAD)

29th Annual Symposium American Medical Directors Association

Lahue BJ


Infectious
Economic
Conference Abstract/Poster
2006

Clostridium Difficile-Associated Diarrhea (CDAD) In Acute Hospitals - A Prevalent Cost Issue

ISPOR 2006

OBrien JA, PitoniakMorse C, Lahue BJ, Davidson D, Wilson D, Caro JJ


Infectious
Other
Conference Abstract/Poster
2005

Using advanced simulation modeling to examine the impact of increased resources on patient throughput in outpatient care

Value in Health

Lahue BJ, Lacey MJ, Dronzek R


Infectious
Economic
Conference Abstract/Poster
2004

Patient Throughput and Staff Efficiency in an Outpatient Health Care Setting

6th Annual Simulation Solutions Conference

[Lahue] Justason BJ


Mental Health
Other
Manuscript
2018

Home care workers’ experiences of client death and disenfranchised grief

Qualitative Health Research

Tsui EK, Franzosa E, Cribbs KA, Baron S


Mental Health
Qualitative
Manuscript
2013

Advocacy at the end of life: Meeting the needs of vulnerable patients

Social Work in Health Care

Nedjat-Haiem FR, Carrion IV, Cribbs K, Lorenz K


Mental Health
Other
Manuscript
2001

Severity, Manifestations, and Consequences of Violence among Pregnant Adolescents

Journal of Adolescent Health

Covington DL, [Lahue] Justason BJ, Wright LN


Neurology
Literature Review
Manuscript
2025

An Evaluation of the Real-World Effectiveness of Immunoglobulin Therapy in Chronic Inflammatory Demyelinating Polyneuropathy

Neurology and Therapy

Hubsch, A., Divino, V., Mallick, R., Coyle K., Langford E., Wang Y., Ida F., Lahue BJ., Zhang X.


Neurology
Literature Review
Conference Abstract/Poster
2025

G17 Expected costs and costs per responder of Hizentra in comparison with other maintenance therapies for chronic inflammatory demyelinating polyneuropathy in the United States

AMCP Annual Meeting 2025, JMCP

Tran D, Mallick R, Patel B, Henry C, Hubsch A, Li Y, Lahue BJ


Neurology
Economic
Manuscript
2007

Treatment of Unruptured Intracranial Aneurysms: A Nationwide Assessment of Effectiveness

American Journal of Neuroradiology

Higashida RT, Lahue BJ, Torbey MT, Hopkins LN, Leip E, Hanley DF


Oncology
Literature Review
Conference Abstract/Poster
2025

Underreporting of prognostic factors in real-world studies for bispecifics in relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL)

ASH

Xavier M, Baginska E, Jun M, Branchcomb T, Mutebi A, Tybor D, Wang A, Cribbs K, Lahue B


Oncology
Economic
Conference Abstract/Poster
2025

PCR231 Beyond the Numbers: Measuring the Real-Life Impact of Medical Treatments via Patient-Level Modeling

ISPOR 2025, Value in Health 28(S1)

Kristen A. Cribbs; Ethan Donnelly; Linda Upchurch; Samantha Watson; Betsy J. Lahue


Oncology
Literature Review
Manuscript
2025

Clinical and safety outcomes in unresectable, very early and early-stage hepatocellular carcinoma following Irreversible Electroporation (IRE) and Transarterial Chemoembolization (TACE): A systematic literature review and meta-analysis

PLOS ONE

Kristen A. Cribbs; Wesley T. Baisley; Betsy J. Lahue; Praveen Peddu


Oncology
Economic
Conference Abstract/Poster
2023

Practice efficiency of treatment with epcoritamab versus glofitamab in relapsed/refractory diffuse large B-cell lymphoma

ASCO 2023

Meyer K, Huang D, O'Day K, Lahue BJ


Oncology
Survey
Conference Abstract/Poster
2023

Burden of Systemic Mastocytosis in Europe and the UK: Interim Results from PRISM Patient Survey

ECRD 2024, Value in Health

Hobart J, Radia DH, Triggiani M, Butt NM, Drummond M, Baisley W, Lahue BJ, Green T, Powell D, Gressier-Sayag C, Mesa R


Oncology
Literature Review
Manuscript
2023

Real-World Comparative Safety and Effectiveness of Irreversible Electroporation and High-Intensity Focused Ultrasound for Prostate Cancer Ablation

Urology

Cribbs KA, Manning EF, Zhou J, Lahue BJ, Polascik TJ


Oncology
Economic
Manuscript
2023

Practice efficiency of treatment with epcoritamab versus glofitamab in relapsed/refractory diffuse large B-cell lymphoma

ASCO 2023

Meyer K, Huang D, O'Day K, Lahue BJ


Oncology
Survey
Manuscript
2023

Assessment of Physician Treatment Preferences for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

National Comprehensive Cancer Network, Journal of the National Comprehensive Cancer Network

Gao W, Gaburo K, Lahue B, Davies K, Ukropec J, Jun M


Oncology
Survey
Manuscript
2022

Patient-reported outcomes among patients with systemic mastocytosis in routine clinical practice: results of the TouchStone SM Patient Survey

Cancer

Mesa RA, Sullivan EM, Dubinski D, Carroll B, Slee VM, Jennings SV, Finnerty CC, Bohannon LS, Mathias SD, Lahue BJ, Castells MC


Oncology
Survey
Manuscript
2022

Perceptions of patient disease burden and management approaches in systemic mastocytosis: Results of the TouchStone Healthcare Provider Survey

Cancer

Mesa RA, Sullivan EM, Dubinski D, Carroll B, Slee VM, Jennings SV, Finnerty CC, Bohannon LS, Mathias SD, Lahue BJ, Castells MC


Oncology
Claims
Manuscript
2020

Real-World Clinical Outcomes of Patients with Myelofibrosis Treated with Ruxolitinib: Evidence from a Multinational Medical Record Review

American Society of Hematology Annual Meeting (ASH), Blood

Passamonti F, Heidel FH, Parikh RC, Tang D, Lahue BJ, Nadal JA, Davis KL, Ajmera M, Kee A, Abraham P


Oncology
Claims
Manuscript
2020

Real-World Clinical Outcomes of Patients with Myelofibrosis Treated with Ruxolitinib: Evidence from a Multinational Medical Record Review

Blood

Passamonti F, Heidel FH, Parikh RC, Tang D, Lahue BJ, Nadal JA, Davis KL, Ajmera M, Kee A, Abraham P


Oncology
Economic
Conference Abstract/Poster
2019

PCN102 Impact of Global Indication Sequencing on Drug Pricing and Access in Oncology: Potential Implications of Using a Price-Based Commercial Sequencing Strategy

Value in Health, ISPOR 2019

M. Klietmann, Crowther A.


Oncology
Policy Review
Manuscript
2015

Health technology assessment on cervical cancer screening, 2000-2014

Int J Technol Assess Health Care

Lahue BJ, Baginska E, Li SS, Parisia M


Oncology
Economic
Manuscript
2012

National burden of preventable adverse drug events associated with inpatient injectable medications: healthcare and medical professional liability costs

American Health Drug Benefits

Lahue BJ, Pyenson B, Iwasaki K, Blumen HE, Forray S, Rothschild JM


Oncology
Literature Review
Manuscript
2012

Data Linkage For Cervical Cancer Outcomes: Is There an Evidence Base for Public Health Decision-Making?

17th Annual ISPOR

Lahue BJ, Lin AY, Crilly HJ


Oncology
Policy Review
Manuscript
2012

A Review of Health Technology Assessments (HTA) for Cervical Cancer Screening Technologies

17th Annual ISPOR

Lahue BH, Baginska E


Rare Disease
Literature Review
Manuscript
2026

PROM-ising Progress? Trends in Patient- and Clinician-Reported Outcome Measures in US Food and Drug Administration Orphan Drug Labels

Value in Health

Cribbs KA, Blackmore LTA, McGovern MR, Lahue BJ


Rare Disease
Literature Review
Manuscript
2025

Capturing Real‐World Rare Disease Patient Journeys: Are Current Methodologies Sufficient for InformedHealthcare Decisions?

Journal of Evaluation in Clinical Practice

Cribbs KA, Blackmore LTA, Banks AR, Kim DS, Lahue BJ


Rare Disease
Policy Review
Conference Abstract/Poster
2025

PT14 Do Breakthrough Therapies Demonstrate Breakthrough Value to Payers? An Evaluation of US Hemophilia B Gene Therapy Access Policies

ISPOR 2025, Value in Health 28(S1)

Lake D. Murphy; Betsy J. Lahue


Rare Disease
Literature Review
Manuscript
2025

Capturing Real-World Rare Disease Patient Journeys: Are Current Methodologies Sufficient for Informed Healthcare Decisions?

Journal of Evaluation in Clinical Practice

Kristen A. Cribbs; Lucas T. A. Blackmore; Asia R. Banks; Da Sol Kim; Betsy J. Lahue


Rare Disease
Literature Review
Conference Abstract/Poster
2025

PCR25 PROM-ising Progress? Patient-Reported Outcome Measures in Orphan Labels

ISPOR 2025, Value in Health 28(S1)

Kristen A. Cribbs; Lucas T. Blackmore; Betsy J. Lahue


Rare Disease
Literature Review
Conference Abstract/Poster
2025

Clinician-Reported Outcomes - A Rare Opportunity for Orphan Labels?

ISPOR 2025, Value in Health 28(S1)

Kristen A. Cribbs; Lucas T. Blackmore; Betsy J. Lahue


Rare Disease
Literature Review
Manuscript
2025

PROM-ising Progress? Trends in Patient- and Clinician-Reported Outcome Measures in FDA Orphan Drug Labels

Value in Health

Kristen A. Cribbs; Lucas T. A. Blackmore; Michael R. McGovern; Betsy J. Lahue


Rare Disease
Literature Review
Conference Abstract/Poster
2024

Capturing real-world rare disease patient journeys: Are current methodologies sufficient?

ISPOR EU 2024

Cribbs KA, Blackmore LTA, Banks AR, Kim DS, Lahue BJ


Rare Disease
Economic
Conference Abstract/Poster
2024

Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin and Efgartigimod Alfa in Patients with CIDP in the United States (P10-11.028)

AAN 2025, Neurology 104(7_Supplement_1)

Rajiv Mallick; Alphonse Hubsch; Rashad Carlton; Joris van Stiphout; Betsy Lahue


Autoimmune
Claims
Conference Abstract/Poster
2025

Real-world Safety Assessment of Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with Subcutaneous IgPro20

PNS 2024, Neurology

Divino V, Mallick R, Lahue B, Coyle K, Wang Y, DeKoven M, Hubsch A


Autoimmune
Claims
Conference Abstract/Poster
2024

Real-world Safety Assessment of Treatment of Chronic Inflammatory Demyelinating Polyneuropathy with Subcutaneous IgPro20

PNS 2024

Divino V, Mallick R, Lahue B, Coyle K, Wang Y, DeKoven M, Hubsch A


Autoimmune
Claims
Conference Abstract/Poster
2023

Treatment Patterns Among Individuals with Hereditary Angioedema in the United States

Annals of Allergy, Asthma & Immunology

Tachdjian R, Chang R, DerSarkissian M, Cribbs K, Lahue B, Czado S, Desai V


Autoimmune
Claims
Manuscript
2022

Reduced risk of infections with the intravenous immunoglobulin, IgPro10, in patients at risk of secondary immunodeficiency-related infections

Immunotherapy

Lahue BJ, Mallick R, Zhang X, Heidt J, Song Y, Koenig AS, Espinoza G


Autoimmune
Claims
Manuscript
2021

Infections in Secondary Immunodeficiency Patients Treated with IgPro10: A Real‑World Analysis of Patients, Including Those with Hematological Malignancies

Blood

Lahue B, Mallick R, Zhang X, Koenig AS, Espinoza G


Autoimmune
Claims
Conference Abstract/Poster
2021

Infections in Secondary Immunodeficiency Patients Treated with IgPro10: Real World Analysis of Patients, Including Those with Hematological Malignancies

American Society of Hematology Annual Meeting (ASH) 2021

Lahue B, Mallick R, Zhang X, Koenig AS, Espinoza G


Oncology
Claims
Manuscript
2020

Real-World Clinical Outcomes of Patients with Myelofibrosis Treated with Ruxolitinib: Evidence from a Multinational Medical Record Review

American Society of Hematology Annual Meeting (ASH), Blood

Passamonti F, Heidel FH, Parikh RC, Tang D, Lahue BJ, Nadal JA, Davis KL, Ajmera M, Kee A, Abraham P


Oncology
Claims
Manuscript
2020

Real-World Clinical Outcomes of Patients with Myelofibrosis Treated with Ruxolitinib: Evidence from a Multinational Medical Record Review

Blood

Passamonti F, Heidel FH, Parikh RC, Tang D, Lahue BJ, Nadal JA, Davis KL, Ajmera M, Kee A, Abraham P


Endocrine
Claims
Manuscript
2015

Adherence to Insulin Pen Therapy is Associated with Reduction in Healthcare Costs Among Patients with Type 2 Diabetes Mellitus

American Health Drug Benefits

Chandran A, Bonafede MK, Nigam S, Saltiel-Berzin R, Hirsch LJ, Lahue BJ


Endocrine
Claims
Conference Abstract/Poster
2014

Pen Needle Length And Persistence Among Insulin Pen Users With Type 2 Diabetes Mellitus

ISPOR 2014

Manocchio J, Chandran A, Bonafede MM, Saltiel-Berzin R, Hirsch LJ, Lahue BJ


None
Claims
Manuscript
2013

Characterization of Injectable Medication Errors in the Hospital Setting: A Retrospective Analysis

18th Annual ISPOR

Baginska EA, Kelley L, Lahue BJ


Endocrine
Claims
Manuscipt
2013

Burden of Health Resource Utilization Among Insulin Pen Users with Type 2 Diabetes Mellitus

18th Annual ISPOR

Chandran A, Bonafede MK, Nigam S, Saltiel-Berzin R, Hirsch LJ, Lahue BJ


Endocrine
Claims
Manuscipt
2013

Adherence to Insulin Therapy may Substantially Reduce Costs Associated with Health Resource Utilization among Insulin Pen Users with Type II Diabetes Mellitus

18th Annual ISPOR

Chandran A, Bonafede MK, Nigam S, Saltiel-Berzin R, Hirsch LJ, Lahue BJ


Infectious
Claims
Conference Abstract/Poster
2007

Does First-line Therapy Impact Clostridium difficile-associated Disease (CDAD) Recurrence Hospitalizations?

Infectious Diseases Society of America (IDSA) Annual Meeting

Lahue BJ


Infectious
Claims
Conference Abstract/Poster
2006

Increased Management Needs, Functional Dependency and Staff Resources for Nursing Home Residents with Clostridium difficile-Associated Diarrhea (CDAD)

29th Annual Symposium American Medical Directors Association

Lahue BJ


Cardiovascular
Claims
Manuscript
2005

Medicare costs and health care resource utilization associated with atrial fibrillation in the elderly

Journal of Medical Economics

Pelletier EM, Hernandez J, Clark MA, Lahue BJ, Reyes CM, Morady F


Oncology
Economic
Conference Abstract/Poster
2025

PCR231 Beyond the Numbers: Measuring the Real-Life Impact of Medical Treatments via Patient-Level Modeling

ISPOR 2025, Value in Health 28(S1)

Kristen A. Cribbs; Ethan Donnelly; Linda Upchurch; Samantha Watson; Betsy J. Lahue


Rare Disease
Economic
Conference Abstract/Poster
2024

Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin and Efgartigimod Alfa in Patients with CIDP in the United States (P10-11.028)

AAN 2025, Neurology 104(7_Supplement_1)

Rajiv Mallick; Alphonse Hubsch; Rashad Carlton; Joris van Stiphout; Betsy Lahue


None
Economic
Conference Abstract/Poster
2024

Economic Evaluations of Digital Health Interventions: Is Existing Guidance Being Used?

ISPOR 2024

Baisley W, Lahue BJ


Autoimmune
Economic
Conference Abstract/Poster
2024

Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin, and Efgartigimod Alfa in Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in the United States

ISPOR 2024, Value in Health

Mallick R, Carlton R, van Stiphout J, Hubsch A, Lahue BJ


Oncology
Economic
Conference Abstract/Poster
2023

Practice efficiency of treatment with epcoritamab versus glofitamab in relapsed/refractory diffuse large B-cell lymphoma

ASCO 2023

Meyer K, Huang D, O'Day K, Lahue BJ


None
Economic
Manuscipt
2023

Creating an evidence-based economic model for prefilled parenteral medication delivery in the hospital setting

European Journal of Hospital Pharmacy

Eijsink JFH, Weiss M, Taneja A, Edwards T, Girgis H, Lahue BJ, Cribbs KA, Postma M


Oncology
Economic
Manuscript
2023

Practice efficiency of treatment with epcoritamab versus glofitamab in relapsed/refractory diffuse large B-cell lymphoma

ASCO 2023

Meyer K, Huang D, O'Day K, Lahue BJ


None
Economic
Manuscript
2023

Creating an evidence-based economic model for prefilled parenteral medication delivery in the hospital setting

European Journal of Hospital Pharmacy

Eijsink JFH, Weiss M, Taneja A, Edwards E, Girgis H, Lahue BJ, Cribbs KA, Postma M


None
Economic
Manuscript
2022

Making the case for pre-filled syringes: development and utilisation of an economic model

European Journal of Hospital Pharmacy

Postma MJ, Weiss M, Edwards T, Girgis H, Cribbs K, Acker E, Lahue BJ


Oncology
Economic
Conference Abstract/Poster
2019

PCN102 Impact of Global Indication Sequencing on Drug Pricing and Access in Oncology: Potential Implications of Using a Price-Based Commercial Sequencing Strategy

Value in Health, ISPOR 2019

M. Klietmann, Crowther A.


Infectious
Economic
Manuscript
2014

Controlling Vaccine Wastage with Smaller Vials: A Cost-Minimization Model for Bangladesh, Mozambique, India (Uttar Pradesh), and Uganda

7th Annual Vaccine and ISV Congress

Yang W, Parisi M, Lahue B, Uddin J, Bishai D


Infectious
Economic
Manuscipt
2014

The budget impact of controlling wastage with smaller vials: A data driven model of session sizes in Bangladesh, India (Uttar Pradesh), Mozambique and Uganda

Vaccine

Yang W, Parisi M, Lahue BJ, Uddin MJ, Bishai D


Infectious
Economic
Manuscript
2013

Examining the Impact of Country-level Factors of Vaccine Wastage: A Data Driven Model of Session Sizes in Bangladesh, Mozambique, India (Uttar Pradesh), and Uganda

16th Annual ISPOR European Congress

Yang W, Parisi M, Lahue B, Uddin J, Bishai D


Oncology
Economic
Manuscript
2012

National burden of preventable adverse drug events associated with inpatient injectable medications: healthcare and medical professional liability costs

American Health Drug Benefits

Lahue BJ, Pyenson B, Iwasaki K, Blumen HE, Forray S, Rothschild JM


Nephrology
Economic
Conference Abstract/Poster
2010

Decreased Epoetin Utilization Associated with Conversion to Ferumoxytol IV Iron Protocol

American Society of Nephrology (ASN) Renal Week Meeting

Sharma A, Lahue BJ


Nephrology
Economic
Conference Abstract/Poster
2010

Efficiency Outcomes Associated with Increased Ferumoxtyol Use in an Infusion Clinic

American Society of Hematology Annual Meeting (ASH)

Meyers M, Erdal E, Khan C, McKee A, Lahue BJ


Infectious
Economic
Conference Abstract/Poster
2009

Consequences of Hepatitis C Virus (HCV): Costs of a Baby Boomer Epidemic of Liver Disease

Milliman Actuarial White Paper

Fitch K, Iwasaki K, Pyenson B


None
Economic
Manuscript
2008

Inclusion of indirect cost in economic outcome analyses of medical devices: How important is it?

6th Annual International Society of Pharmacoeconomics and Outcomes Research

Subramanian S, [Lahue] Justason BJ


Endocrine
Economic
Conference Abstract/Poster
2007

Economic Impact of Hydro ThermAblater® (HTA) Endometrial Ablation versus Hysterectomy for Dysfunctional Uterine Bleeding (DUB)

American Association of Gynecologic Laparoscopy

[Lahue] Justason BJ


Infectious
Economic
Manuscript
2007

The Emerging Infectious Challenge of Clostridium difficile-Associated Disease in Massachusetts Hospitals: Clinical and Economic Consequences

Journal of Infection Control and Hospital Epidemiology

O'Brien JA, Lahue BJ, Caro JJ, Davidson DM


Neurology
Economic
Manuscript
2007

Treatment of Unruptured Intracranial Aneurysms: A Nationwide Assessment of Effectiveness

American Journal of Neuroradiology

Higashida RT, Lahue BJ, Torbey MT, Hopkins LN, Leip E, Hanley DF


Cardiovascular
Economic
Manuscript
2006

TAXUS-IV Investigators. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial

J Am Coll Cardiol

Bakhai A, Stone GW, Mahoney E, Lavelle TA, Shi C, Berezin RH, Lahue BJ, Clark MA, Lacey MJ, Russell ME, Ellis SG, Hermiller JB, Cox DA, Cohen DJ


Infectious
Economic
Conference Abstract/Poster
2006

Clostridium Difficile-Associated Diarrhea (CDAD) In Acute Hospitals - A Prevalent Cost Issue

ISPOR 2006

OBrien JA, PitoniakMorse C, Lahue BJ, Davidson D, Wilson D, Caro JJ


Infectious
Economic
Conference Abstract/Poster
2004

Patient Throughput and Staff Efficiency in an Outpatient Health Care Setting

6th Annual Simulation Solutions Conference

[Lahue] Justason BJ


Rare Disease
Literature Review
Manuscript
2026

PROM-ising Progress? Trends in Patient- and Clinician-Reported Outcome Measures in US Food and Drug Administration Orphan Drug Labels

Value in Health

Cribbs KA, Blackmore LTA, McGovern MR, Lahue BJ


Other
Literature Review
Conference Astract/oster
2025

Delivering Pharma Value: Where Is the Optimal Home for Health Economics and Outcomes Research (HEOR)?

ISPOR 2025

Betsy JH., Shuvayu S.


Neurology
Literature Review
Manuscript
2025

An Evaluation of the Real-World Effectiveness of Immunoglobulin Therapy in Chronic Inflammatory Demyelinating Polyneuropathy

Neurology and Therapy

Hubsch, A., Divino, V., Mallick, R., Coyle K., Langford E., Wang Y., Ida F., Lahue BJ., Zhang X.


Neurology
Literature Review
Conference Abstract/Poster
2025

G17 Expected costs and costs per responder of Hizentra in comparison with other maintenance therapies for chronic inflammatory demyelinating polyneuropathy in the United States

AMCP Annual Meeting 2025, JMCP

Tran D, Mallick R, Patel B, Henry C, Hubsch A, Li Y, Lahue BJ


Oncology
Literature Review
Conference Abstract/Poster
2025

Underreporting of prognostic factors in real-world studies for bispecifics in relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL)

ASH

Xavier M, Baginska E, Jun M, Branchcomb T, Mutebi A, Tybor D, Wang A, Cribbs K, Lahue B


Rare Disease
Literature Review
Manuscript
2025

Capturing Real‐World Rare Disease Patient Journeys: Are Current Methodologies Sufficient for InformedHealthcare Decisions?

Journal of Evaluation in Clinical Practice

Cribbs KA, Blackmore LTA, Banks AR, Kim DS, Lahue BJ


Autoimmune
Literature Review
Conference Abstract/Poster
2025

Budget Impact of Subcutaneous Immunoglobulin, Intravenous Immunoglobulin and Efgartigimod Alfa in Patients with Chronic Inflammatory Demyelinating Polyneuropathy in the United States

AAN Annual Meeting 2025, eurology

Hubsch A, Mallick R, Carlton R, van Stiphout J, Lahue BJ


Rare Disease
Literature Review
Manuscript
2025

Capturing Real-World Rare Disease Patient Journeys: Are Current Methodologies Sufficient for Informed Healthcare Decisions?

Journal of Evaluation in Clinical Practice

Kristen A. Cribbs; Lucas T. A. Blackmore; Asia R. Banks; Da Sol Kim; Betsy J. Lahue


Rare Disease
Literature Review
Conference Abstract/Poster
2025

PCR25 PROM-ising Progress? Patient-Reported Outcome Measures in Orphan Labels

ISPOR 2025, Value in Health 28(S1)

Kristen A. Cribbs; Lucas T. Blackmore; Betsy J. Lahue


Oncology
Literature Review
Manuscript
2025

Clinical and safety outcomes in unresectable, very early and early-stage hepatocellular carcinoma following Irreversible Electroporation (IRE) and Transarterial Chemoembolization (TACE): A systematic literature review and meta-analysis

PLOS ONE

Kristen A. Cribbs; Wesley T. Baisley; Betsy J. Lahue; Praveen Peddu


Rare Disease
Literature Review
Conference Abstract/Poster
2025

Clinician-Reported Outcomes - A Rare Opportunity for Orphan Labels?

ISPOR 2025, Value in Health 28(S1)

Kristen A. Cribbs; Lucas T. Blackmore; Betsy J. Lahue


Rare Disease
Literature Review
Manuscript
2025

PROM-ising Progress? Trends in Patient- and Clinician-Reported Outcome Measures in FDA Orphan Drug Labels

Value in Health

Kristen A. Cribbs; Lucas T. A. Blackmore; Michael R. McGovern; Betsy J. Lahue


None
Literature Review
Manuscript
2024

Assessing the Clinical, Economic, and Health Resource Utilization Impacts of Prefilled Syringes Versus Conventional Medication Administration Methods: Results From a Systematic Literature Review

The Annals of Pharmacotherapy

Benhamou D, Weiss M, Borms M, Lucaci J, Haymen G, Frolet C, Baisley W, Shoushi G, Cribbs KA, Wenk M


None
Literature Review
Conference Abstract/Poster
2024

Does Availability of Rare Disease Treatment Improve Time to Diagnosis?

ISPOR 2024

Baisley W


Rare Disease
Literature Review
Conference Abstract/Poster
2024

Capturing real-world rare disease patient journeys: Are current methodologies sufficient?

ISPOR EU 2024

Cribbs KA, Blackmore LTA, Banks AR, Kim DS, Lahue BJ


None
Literature Review
Conference Abstract/Poster
2024

Can Artificial Intelligence Tools Enhance Data Abstraction During Systematic Literature Reviews?

ISPOR 2024

Cribbs KA, Baisley W, Blackmore LTA, Lahue BJ


None
Literature Review
Conference Abstract/Poster
2024

An Investigation of Patient Journey Assessment in Rare Disease

ISPOR 2024

Cribbs KA, Kim DS, Lahue BJ


Autoimmune
Literature Review
Conference Abstract/Poster
2024

Budget impact of subcutaneous immunoglobulin, intravenous immunoglobulin and Efgartigimod Alfa in patients with chronic inflammatory demyelinating polyneuropathy in the United States

American Health -System Pharmacy (ASHP mid-year) 2024, Am J Health-Syst Pharm

Hubsch A, Mallick R, Carlton R, van Stiphout J, Lahue BJ


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Assessing the Potential Benefits of Oral Therapies in Hereditary Angioedema

Academy of Managed Care Pharmacy (AMCP) Conference

Soteres DF, Cribbs KA, Guo W, Czado S


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Characterizing Attack-Related Health Utility in Hereditary Angioedema

ISPOR 2023

Craig TJ, Cribbs KA, Czado S


Autoimmune
Literature Review
Conference Abstract/Poster
2023

A Systematic Review of Healthcare Resource Utilization and Direct Medical Costs in Hereditary Angioedema

ISPOR 2023

Craig TJ, Cribbs KA, Czado S


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Assessing the Burden of Injection with Parenteral Hereditary Angioedema Therapies

ISPOR 2023

Soteres DF, Cribbs KA, Czado S


Autoimmune
Literature Review
Conference Abstract/Poster
2023

PCR81 Diagnosis and Treatment Patterns in European Patients with Systemic Mastocytosis

ISPOR EU 2023, Value in Health

Triggiani M, Mesa R, Hobart J, Green T, Powell D, Gressier-Sayag C, Baisley W, Lahue BJ, Rueff F, Schinhofen W, Hegmann N, Livideanu CB, Beaux A, Marcis P, Alvarez-Twose I, Ribada E, Radia D, Finnerty CC


Autoimmune
Literature Review
Manuscript
2023

Assessing the Utility of Existing Hereditary Angioedema Disease Models for Health Economic Evaluation of Future Therapies

ISPOR 2023

Schwander B, Lahue BJ, Cribbs KA, Czado S


Oncology
Literature Review
Manuscript
2023

Real-World Comparative Safety and Effectiveness of Irreversible Electroporation and High-Intensity Focused Ultrasound for Prostate Cancer Ablation

Urology

Cribbs KA, Manning EF, Zhou J, Lahue BJ, Polascik TJ


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Current State of Health Economic Models in Hereditary Angioedema

ISPOR EU 2023

Tachdjian R, Lahue BJ, Cribbs KA, Fang DK, Czado S, Goga L, Desai V, Rautenberg T, Schwander B


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Assessing the Burden of Injection with Parenteral Hereditary Angioedema Therapies

ISPOR 2023

Soteres DF, Cribbs KA, Czado S


Autoimmune
Literature Review
Manuscript
2023

A Systematic Review of Socioeconomic Burden in Hereditary Angioedema

ISPOR 2023

Soteres DF, Cribbs KA, Czado S


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Diagnosis Patterns in Patients with Systemic Mastocytosis in Europe and United Kingdom

ISPOR EU 2023

Triggiani M, Mesa R, Hobart J, Green T, Powell D, Gressier-Sayag C, Baisley W, Lahue BJ, Rueff F, Schinhofen W, Hegmann N, Livideanu CB, Beaux A, Marcis P, Alvarez-Twose I, Ribada E, Radia D, Finnerty CC


Autoimmune
Literature Review
Manuscript
2023

Characterizing Attack-Related Health Utility in Hereditary Angioedema

ISPOR 2023

Craig TJ, Cribbs KA, Czado S


Autoimmune
Literature Review
Conference Abstract/Poster
2023

Assessing the Potential Benefits of Oral Therapies in Hereditary Angioedema

Academy of Managed Care Pharmacy (AMCP) Conference

Soteres DF, Cribbs KA, Guo W, Czado S


None
Literature Review
Conference Abstract/Poster
2023

Non-Systematic Literature Reviews: Can AI enhance current methods?

ISPOR EU 2023

Baisley W, Perriello L, Shoushi G, Lahue BJ


Autoimmune
Literature Review
Manuscript
2023

A Systematic Review of Healthcare Resource Utilization and Direct Medical Costs in Hereditary Angioedema

ISPOR 2023

Craig TJ, Cribbs KA, Czado S


None
Literature Review
Manuscript
2014

A Systematic Review of the Effectiveness of Health Information Technology Interventions in Improving Medication Adherence

19th Annual ISPOR

Nigam S, Mitra D, Lahue BJ


Oncology
Literature Review
Manuscript
2012

Data Linkage For Cervical Cancer Outcomes: Is There an Evidence Base for Public Health Decision-Making?

17th Annual ISPOR

Lahue BJ, Lin AY, Crilly HJ


Rare Disease
Policy Review
Conference Abstract/Poster
2025

PT14 Do Breakthrough Therapies Demonstrate Breakthrough Value to Payers? An Evaluation of US Hemophilia B Gene Therapy Access Policies

ISPOR 2025, Value in Health 28(S1)

Lake D. Murphy; Betsy J. Lahue


None
Policy Review
Panel/Workshop/Discussion
2024

How to Navigate the Digital Health Landscape: Global Value Frameworks and Payment Pathways

ISPOR 2024

Lahue BJ, Chandran A, Hernandez J


None
Policy Review
Conference Abstract/Poster
2024

Real World Evidence and Rare Disease Considerations Across Regulatory and Health Technology Assessment Frameworks in the US, UK, and Canada

ISPOR 2024

Blackmore LTA, Cribbs KA, Lahue BJ


Endocrine
Policy Review
Article/Report
2015

Can mHealth Revolutionize Evidence-Based Practice in Diabetes Care?

American Journal of Managed Care

Lahue BJ, Hughes K, Hills BJ, Li SS, Hiatt JC


Oncology
Policy Review
Manuscript
2015

Health technology assessment on cervical cancer screening, 2000-2014

Int J Technol Assess Health Care

Lahue BJ, Baginska E, Li SS, Parisia M


Oncology
Policy Review
Manuscript
2012

A Review of Health Technology Assessments (HTA) for Cervical Cancer Screening Technologies

17th Annual ISPOR

Lahue BH, Baginska E


Oncology
Survey
Conference Abstract/Poster
2023

Burden of Systemic Mastocytosis in Europe and the UK: Interim Results from PRISM Patient Survey

ECRD 2024, Value in Health

Hobart J, Radia DH, Triggiani M, Butt NM, Drummond M, Baisley W, Lahue BJ, Green T, Powell D, Gressier-Sayag C, Mesa R


Autoimmune
Survey
Conference Abstract/Poster
2023

The Burden of Systemic Mastocytosis in the EU: Evidence From the PRISM Patient Survey

ISPOR EU 2023

Mesa R, Triggiani M, Hobart J, Green T, Powell D, Gressier-Sayag C, Baisley W, Lahue BJ, Rueff F, Schinhofen W, Hegmann N, Livideanu CB, Beaux A, Marcis P, Alvarez-Twose I, Ribada E, Radia D, Finnerty CC


Oncology
Survey
Manuscript
2023

Assessment of Physician Treatment Preferences for Relapsed or Refractory Diffuse Large B-Cell Lymphoma

National Comprehensive Cancer Network, Journal of the National Comprehensive Cancer Network

Gao W, Gaburo K, Lahue B, Davies K, Ukropec J, Jun M


Oncology
Survey
Manuscript
2022

Patient-reported outcomes among patients with systemic mastocytosis in routine clinical practice: results of the TouchStone SM Patient Survey

Cancer

Mesa RA, Sullivan EM, Dubinski D, Carroll B, Slee VM, Jennings SV, Finnerty CC, Bohannon LS, Mathias SD, Lahue BJ, Castells MC


Oncology
Survey
Manuscript
2022

Perceptions of patient disease burden and management approaches in systemic mastocytosis: Results of the TouchStone Healthcare Provider Survey

Cancer

Mesa RA, Sullivan EM, Dubinski D, Carroll B, Slee VM, Jennings SV, Finnerty CC, Bohannon LS, Mathias SD, Lahue BJ, Castells MC


Autoimmune
Survey
Manuscript
2020

Subcutaneous immunoglobulin in primary immunodeficiency – impact of training and infusion characteristics on patient-reported outcomes

BMC Immunology

Mallick R, Henderson T, Lahue BJ, Kafal A, Bassett P, Scalchunes C


None
Survey
Article Report
2001

The Impact of Educational Home Visits on Children at Risk for Lead Poisoning

Centers For Disease Control Annual Grantees Meeting

[Lahue] Justason BJ


Infectious
Other
Manuscript
2020

Investigating the Impact of the Nursing Practice Environment (NPE) on Central Line- Associated Bloodstream Infections (CLABSI) among Older Adults in the Intensive Care Unit (ICU)

CUNY SPH: Dissertations and Theses

Cribbs K


None
Other
Manuscript
2019

Enhancing graduate practicum project development and selection at schools of public health: A case study

Pedagogy in Health Promotion

Cribbs K, Lynch S, LaMonica M, Amadi C, Joshi A


Mental Health
Other
Manuscript
2018

Home care workers’ experiences of client death and disenfranchised grief

Qualitative Health Research

Tsui EK, Franzosa E, Cribbs KA, Baron S


Infectious
Other
Conference Abstract/Poster
2005

Using advanced simulation modeling to examine the impact of increased resources on patient throughput in outpatient care

Value in Health

Lahue BJ, Lacey MJ, Dronzek R


Mental Health
Other
Manuscript
2001

Severity, Manifestations, and Consequences of Violence among Pregnant Adolescents

Journal of Adolescent Health

Covington DL, [Lahue] Justason BJ, Wright LN


Other (Neonatal & Opthamology)
Other
Conference Abstract/Poster
2000

Use of Continuous Quality Improvement Principles to Increase Preventive Screenings in High-Risk Infants

128th American Public Health Association Annual Meeting and Exposition

[Lahue] Justason BJ, Sachariat ML, McArtor RD


Discover The Best Path Forward With Alkemi

Schedule a consultation below. Together, we’ll look at your situation and explore your value proposition. If we can help, we’ll explain how. If not, we’ll connect you with a partner who can.